K Mosterd, MD, PhD
Maastricht University Medical Center
Emerging Leaders
#2231 pts
Current Leaders
#21,8222 pts
All-Time Leaders
#31331 pts
Scored by the scientific impact (publications, citations, press) of the trials they lead, weighted by role. First trial 2021. 7 trials as lead/chair. How it works →
Trials led — by scientific impact
The Needs and Preferences of Patients With High-risk Cutaneous Squamous Cell Carcinomas in the Head Neck Region: a Qualitative Approach
N/AActiveMaastricht University Medical Center
7
impact
Registration of Oral Hedgehog Inhibitors Vismodegib and Sonidegib in the Treatment of Advanced and Multiple Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study.
N/ARecruitingMaastricht University Medical Center
6
impact
The Value of Optical Coherence Tomography in Discrimination Between the Presence and Absence of Invasion in Clinical Actinic Keratosis
N/ACompletedMaastricht University Medical Center
5
impact
Decisional Conflicts, Health-related Quality of Life and Satisfaction With Care in High-risk Cutaneous Squamous Cell Carcinoma in the Head-neck Region: Validated Questionnaires
N/ACompletedMaastricht University Medical Center
5
impact
Clinical Presentation and Surgical Outcomes in Patients With Skin Disorders Treated With Mohs Micrographic Surgery and Slow Mohs.
N/AActiveMaastricht University Medical Center
4
impact
Desmoplasia in Cutaneous Squamous Cell Carcinoma: Inter Observer Agreement Between Dermatopathologists.
N/ACompletedMaastricht University Medical Center
2
impact
Tumor Free Survival in T1 Squamous Cell Carcinomas of the Lip Treated With 5mm or 10mm Surgical Margins.
N/AUnknownMaastricht University Medical Center
2
impact